Partnering with CTI BioPharma
As an emerging commercial-stage biopharmaceutical company, collaboration remains at the core of our DNA. We welcome inquiries from highly qualified partners who can broaden and accelerate clinical trial development and potential commercialization of our product candidates. A partner will generate significant non-equity based operating capital, supplement our own internal expertise and provide us with access to the marketing, sales and distribution capabilities of our collaborators in specific territories.
A core element of our corporate strategy is to identify and acquire additional pipeline opportunities. Our current pipeline is the result of licensing and acquiring assets that we believe to be undervalued opportunities. We plan to continue to be opportunistic in seeking additional product candidates, and welcome high-quality drug candidates that offer the potential to advance the care of people affected by hematological malignancies and solid tumors. We are open to opportunities ranging from commercial-stage to preclinical targeted therapies.
Our scientific, regulatory and commercial expertise, combined with our ability to be nimble and open to creative collaboration structures, makes us an ideal partner for organizations that share our focus on hematology/oncology, innovation and commitment to improving the lives of patients.
To discuss partnering opportunities, please contact Corporate Development.